Pricing Log in Create free account

Nasus Pharma Ltd. (NSRX) vs Scilex Holding Company (SCLX)

Nasus Pharma Ltd. and Scilex Holding Company are both Drug Manufacturers General companies. Nasus Pharma Ltd. is the larger, with a market value of $37.1M against $19.8M — 1.9× the size. Across the 8 metrics below, Nasus Pharma Ltd. leads on 5 and Scilex Holding Company on 3.

Valuation

Metric NSRX SCLX Drug Manufacturers General median
P/E — n/m 24.54
P/S — 0.62 3.39
P/B n/m n/m 5.00
Price to free cash flow n/m n/m 16.55
EV/EBITDA n/m n/m 13.82
EV/Sales n/m 3.18 4.03
Earnings yield — (1,756.18%) 2.98%
Free cash flow yield 0.00% (91.35%) 4.46%

Profitability

Metric NSRX SCLX Drug Manufacturers General median
Gross margin — 55.50% 72.77%
Operating margin — (1,136.40%) 18.77%
Net margin — (1,418.45%) 8.27%
Free cash flow margin 0.00% (56.37%) 17.18%
Return on equity 0.00% 160.27% 5.87%
Return on assets 0.00% (265.83%) 2.57%
Return on invested capital 0.00% 0.00% 6.11%

Growth

Metric NSRX SCLX Drug Manufacturers General median
Revenue growth (TTM) — (28.55%) 6.66%
EPS growth (last fiscal year) (231.82%) (408.32%) 21.81%
Revenue growth, 5-year CAGR — 5.13% 4.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric NSRX SCLX Drug Manufacturers General median
Debt to equity 0.00 (0.26) 0.63
Current ratio 8.77 0.07 1.32
Net debt to EBITDA 0.26 (0.27) 1.15

Dividend

Metric NSRX SCLX Drug Manufacturers General median
Dividend yield — — 2.33%
Payout ratio — — 0.59

Size

Metric NSRX SCLX Drug Manufacturers General median
Market cap 37.06m 19.84m 123.73b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack